期刊
ELIFE
卷 9, 期 -, 页码 -出版社
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.46775
关键词
-
类别
资金
- National Institutes of Health [AG054022, R01AG060149]
- MRC [MC_U105184291] Funding Source: UKRI
Seeding, in the context of amyloid disease, is the sequential transfer of pathogenic protein aggregates from cell-to-cell within affected tissues. The structure of pathogenic seeds provides the molecular basis and enables rapid conversion of soluble protein into fibrils. To date, there are no inhibitors that specifically target seeding of Parkinson's disease (PD)-associated alpha-synuclein (alpha-syn) fibrils, in part, due to lack of information of the structural properties of pathological seeds. Here we design small peptidic inhibitors based on the atomic structure of the core of alpha-syn fibrils. The inhibitors prevent alpha-syn aggregation in vitro and in cell culture models with binding affinities of 0.5 mM to alpha-syn fibril seeds. The inhibitors also show efficacy in preventing seeding by human patient-derived alpha-syn fibrils. Our results suggest that pathogenic seeds of alpha-syn contain steric zippers and suggest a therapeutic approach targeted at the spread and progression that may be applicable for PD and related synucleinopathies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据